🇺🇸 clopidogrel bisulfate + aspirin in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 4
Most-reported reactions
- Asthenia — 1 report (25%)
- Gait Disturbance — 1 report (25%)
- Muscular Weakness — 1 report (25%)
- Myalgia — 1 report (25%)
Other Cardiovascular approved in United States
Frequently asked questions
Is clopidogrel bisulfate + aspirin approved in United States?
clopidogrel bisulfate + aspirin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for clopidogrel bisulfate + aspirin in United States?
Seoul National University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.